Smart condition monitoring helps in drive for world-class OEE scores

摘要

As pharmaceutical manufacturers look to boost productivity and minimise downtime, frequently now with the goal of moving from batch production to continuous operation, Neal Welch, life science sales manager, automation systems division at Mitsubishi Electric, highlights the importance of smart condition monitoring technologies As a tightly regulated sector with huge financial incentives to keep production lines running, manufacturers in the pharmaceutical industry typically experience less unplanned downtime than those in other sectors. Indeed, pharmaceutical manufacturers as a whole can point to fewer hours of unscheduled downtime than the equally high value automotive industry and the similarly regulated food and beverage sector.